Skip to main content

Insomnia in Primary Sleep Disorders

  • Chapter
Clinical Handbook of Insomnia

Part of the book series: Current Clinical Neurology ((CCNEU))

  • 253 Accesses

Abstract

Insomnia is defined in the International Classification of Sleep Disorders as “difficulty in initiating and/or maintaining sleep” (1). In primary insomnia, the term insomnia constitutes a diagnostic entity. In other disorders it is considered a symptom and not a primary diagnosis. Insomnia is frequently a component of the symptom complexes of other primary sleep disorders, and is listed among the diagnostic criteria for the following dyssomnias: obstructive sleep apnea (OSA) syndrome, central sleep apnea syndrome, central alveolar hypoventilation syndrome, periodic limb movement disorder (PLMD), and restless legs syndrome (RLS). Disrupted sleep is among the diagnostic criteria for narcolepsy. The complaint of insomnia can also accompany parasomnias, and is listed among the diagnostic criteria for sleep starts and nightmares (1). As in other forms of insomnia, in order to be considered a clinically significant problem, the complaint of sleep disturbance must be associated with adverse daytime consequences such as fatigue, decreased concentration, or irritability.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. American Sleep Disorders Association. (1997) International classification of sleep disorders: diagnostic and coding manual. American Sleep Disorders Association, Rochester, MN.

    Google Scholar 

  2. Lugaresi, E., Coccagna, G., Gambi, D., Ceroni, G. B., and Poppi, M. (1966) Apropos of some nocturnal myoclonic manifestations. Revue Neurologique 115 (3), 547–555.

    PubMed  CAS  Google Scholar 

  3. Young, T., Palta, M., Dempsey, J., et al. (1993) The occurrence of sleep disordered breathing among middle-aged adults. N. Engl. J. Med. 328, 1230–1235.

    Article  PubMed  CAS  Google Scholar 

  4. Guilleminault,C., Eldridge, F. L., and Dement, W. C. (1973) Insomnia with sleep apnea: a new syndrome. Science 181 (8), 856–858.

    Article  PubMed  CAS  Google Scholar 

  5. Krakow, B., Melendrez, D., Ferreira, E., et al. (2001) Prevalence of insomnia symptoms in patients with sleep-disordered breathing. Chest 120, 1923–1929.

    Article  PubMed  CAS  Google Scholar 

  6. Guilleminault, C., Palombini, L., Poyares, D., and Chowdhuri, S. (2001) Chronic insomnia, postmenopausal women, and sleep disordered breathing Part 1. Frequency of sleep disordered breathing in a cohort. J. Psychosom. Res. 53, 611–615.

    Article  Google Scholar 

  7. Roehrs, T., Conway, W., Wittig, R., et al. (1985) Sleep-wake complaints in patients with sleep-related respiratory disturbances. Am. Rev. Respir. Dis. 132, 520–523.

    PubMed  CAS  Google Scholar 

  8. Bradley, T. D., McNicholas, W., Rutherford, R., et al. (1986) Clinical and physiological heterogeneity of the central sleep apnea syndrome. Am. Rev. Respir. Dis. 134, 217–221.

    PubMed  CAS  Google Scholar 

  9. Lavigne, G. and Montplaisir, J. (1994) Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. Sleep 17, 739–743.

    PubMed  CAS  Google Scholar 

  10. Montplaisir, J.,Boucher, S., Poirer, G., Lavigne, G., Lapierre, O., and Lesperance, P. (1996) Clinical polysomnographic and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov. Disord. 12, 61–65.

    Google Scholar 

  11. Coleman, R., Bliwise, D., Sajben, N., et al. (1988) Epidemiology of periodic movements during sleep. In: Sleep/Wake Disorders, Natural History, Epidemiology and Long Term Evolution (Guilleminault, C. and Lugaresi. E., eds.), Raven Press, New York, NY, 217–229.

    Google Scholar 

  12. Coleman, R., Pollak, C., and Weitzman, E. (1980) Periodic movements in sleep (nocturnal myoclonus): relation to sleep disorders. Ann. Neurol. 8, 416–421.

    Article  PubMed  CAS  Google Scholar 

  13. Dement, W., Zarcone, V., Varner, V., et al. (1972) The prevalence of narcolepsy. Sleep Res. 1, 148.

    Google Scholar 

  14. Bassetti, C. and Aldrich, M. (1996) Narcolepsy. Neurol. Clin. 14, 545–571.

    Article  PubMed  CAS  Google Scholar 

  15. Billard, M., Besset, A., and Cadilhac, J. (1983) The clinical and polygraphic development of narcolepsy. In: Sleep/Wake Disorders: Natural History, Epidemiology and Long Term Evolution ( Builleminault, C. and Lugaresi, E., eds.), Raven Press, New York, NY, 187–199.

    Google Scholar 

  16. Stepansky, R., Holzinger, B., Schmeiser-Rieder, A., et al. (1998) Austrian dream behavior: results of a representative population survey. Dreaming 8, 23–30.

    Article  Google Scholar 

  17. Ohayon, M., Morselli, P., and Guilleminault, C. (1997) Prevalence of nightmares and their relationship to psychopathology and daytime functioning in insomnia subjects. Sleep 20, 340–348.

    PubMed  CAS  Google Scholar 

  18. Bastien, C. H. and Morin, C. M. (2000) Familial incidence of insomnia. J. Sleep Res. 9, 49–54.

    Article  PubMed  CAS  Google Scholar 

  19. Remmers, J., deGroot, W., Sauerland, E., et al. (1978) Pathogenesis of upper airway occlusion during sleep. J. Appl. Physiol. 44, 931–938.

    PubMed  CAS  Google Scholar 

  20. Kock, N., Culjkovic, B., Maniak, S., et al. (2002) Mode of inheritance and susceptibility locus for restless legs syndrome, on chromosome 12q. Am. J. Hum. Genet. 71, 205–208.

    Article  PubMed  CAS  Google Scholar 

  21. Ondo, W. and Jankovic, J. (1996) Restless legs syndrome: clincoetiologic correlates. Neurology 47, 1435–1441.

    Article  PubMed  CAS  Google Scholar 

  22. Sandyk, R., Bernick, C., Lee, S., et al. (1987) L-dopa in uremic patients with the restless legs syndrome. Int. J. Neurosci. 35, 233–235.

    Article  PubMed  CAS  Google Scholar 

  23. Matthews, W. (1986) Iron deficiency and restless legs. Br. Med. J. 1, 898.

    Article  Google Scholar 

  24. Heimen, E. and Christie, M. (1986) Lithium-aggravated nocturnal myoclonus and restless legs syndrome. Am. J. Psychiatry 143, 1191–1192.

    Google Scholar 

  25. Ware, J., Brown, F., Moorad, P., et al. (1984) Nocturnal myoclonus and tricyclic antidepressants. Sleep Res. 13, 72.

    Google Scholar 

  26. Bakshi, R. (1996) Fluoxetine and restless legs syndrome. J. Neurol. Sci. 142, 151–152.

    Article  PubMed  CAS  Google Scholar 

  27. Mendelson, W. (1996) Are periodic leg movements associated with clinical sleep disturbance. Sleep 19, 219–223.

    PubMed  CAS  Google Scholar 

  28. Montplaisir, J., Nicolas, A., Denesle, R., and Gomez-Mancilla, B. (1999) Restless legs syndrome imiproved by pramipexole: a double-blind randomized trial. Neurology 52, 938–943.

    Article  PubMed  CAS  Google Scholar 

  29. Lin, L., Faraco, J., Li, R., et al. (1999) The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98, 409–412.

    Article  Google Scholar 

  30. Chemelli, R., Willie, J., Sinton, C., et al. (1999) Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98, 409–412.

    Article  Google Scholar 

  31. Ripley, B., Overeem, S., Fujiki, N., et al. (2001) CSF hypocretin/orexin levels in narcolepsy and other neurological conditions. Neurology 57, 2253–2258.

    Article  PubMed  CAS  Google Scholar 

  32. Peyron, C., Faraco, J., Rogers, W., et al. (2000) A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat. Med. 6, 991–997.

    Article  PubMed  CAS  Google Scholar 

  33. John, J., Wu, M., and Siegel, J. (2000) Systemic administration of hypocretin-1 reduces cataplexy and normalizes sleep and waking durations in narcoleptic dogs. Sleep Research Online 3, 23–28.

    PubMed  CAS  Google Scholar 

  34. Cartwright, R. (1979) The nature and function of repetitive dreams: a survey and speculation. Psychiatry 42, 131–137.

    PubMed  CAS  Google Scholar 

  35. Cove-Smith, J. and Kirk, C. (1985) CNS-related side-effects with metropolol and atenolol. Eur. J. Pharmacol. 28, 69–72.

    Article  Google Scholar 

  36. Sharf, B., Moskovitz, C., Lupton, M., et al. (1978) Dream phenomena induced by chronic levodopa therapy. J. Neural. Trams. 43, 143–151.

    Article  CAS  Google Scholar 

  37. Lepkifker, W., Dannon, P., Iancu, I., et al. (1995) Nightmares related to fluoxetine treatment. Clin. Neuropharmacol. 18, 90–94.

    Article  PubMed  CAS  Google Scholar 

  38. Hershon, H. (1977) Alcohol withdrawal symptoms and drinking behavior. J. Stud. Alcohol. 38, 953–971.

    PubMed  CAS  Google Scholar 

  39. The International Restless Legs Syndrome Study Group. (1995) Towards a better definition of the restless legs syndrome from the international restless legs syndrome study group. Mov. Disord. 10, 634–642.

    Article  Google Scholar 

  40. Roehrs, T., Papineau, K., Rosenthal, L., and Roth, T. (1999) Ethanol as a hypnotic in insomniacs: self-administration and effects on sleep and mood. Neuropsychopharmacology 20 (3), 279–286.

    Article  PubMed  CAS  Google Scholar 

  41. Ford, D. E. and Kamerow, D. B. (1989) Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA 226 (11), 1479–1484.

    Article  Google Scholar 

  42. Chesson, A., Hartse, K., Anderson, W. M., et al. (1999) Practice parameters for the treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Report. Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep 22 (7), 961–968.

    PubMed  Google Scholar 

  43. US Xyrem Multicenter Study Group. (2002) A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy. Sleep 25, 42–49.

    Google Scholar 

  44. Coalson, B. (1995) Nightmare help: treatment of of trauma survivors with PTSD. Psychotherapy 32, 381–388.

    Article  Google Scholar 

  45. Miller, W. and DiPilato, M. (1983) Treatment of nightmares via relaxation and desensitization: a controlled evalustion. J. Consult. Clin. Psychol. 51, 870–877.

    Article  PubMed  CAS  Google Scholar 

  46. Keller, R., et al. (1992) Changes in chronic nightmares after one session of desensitization or rehersal instructions. Am. J. Psychiatry 149, 659–663.

    Google Scholar 

  47. Marquis J. (1991) A report on seventy-eight cases treated by eye movement desensitization. J. Behav. Ther. Exp. Psychiatry 22, 187–192.

    Article  PubMed  CAS  Google Scholar 

  48. Kingsbury, S. J. (1993) Brief hypnotic treatment of repetitive nightmares. Am. J. Clin. Hypn. 35, 161–169.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer Science+Business Media New York

About this chapter

Cite this chapter

Duntley, S. (2004). Insomnia in Primary Sleep Disorders. In: Attarian, H.P. (eds) Clinical Handbook of Insomnia. Current Clinical Neurology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-662-1_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-662-1_12

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-465-4

  • Online ISBN: 978-1-59259-662-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics